Baird William D Iii - Net Worth and Insider Trading

Baird William D Iii Net Worth

The estimated net worth of Baird William D Iii is at least $6 Million dollars as of 2025-05-15. Baird William D Iii is the President and CEO of 2seventy bio Inc and owns about 1,121,034 shares of 2seventy bio Inc (TSVT) stock worth over $6 Million. Baird William D Iii is the CFO of Amicus Therapeutics Inc and owns about 117,622 shares of Amicus Therapeutics Inc (FOLD) stock worth over $691,617. Baird William D Iii is also the CFO of bluebird bio Inc and owns about 1,776 shares of bluebird bio Inc (BLUE) stock worth over $8,844. Details can be seen in Baird William D Iii's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Baird William D Iii has not made any transactions after 2025-03-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Baird William D Iii

To

Baird William D Iii Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Baird William D Iii owns 4 companies in total, including Axcella Health Inc (AXLA) , bluebird bio Inc (BLUE) , and Amicus Therapeutics Inc (FOLD) among others .

Click here to see the complete history of Baird William D Iii’s form 4 insider trades.

Insider Ownership Summary of Baird William D Iii

Ticker Company Transaction Date Type of Owner
AXLA Axcella Health Inc 2019-05-08 director
BLUE bluebird bio Inc 2021-02-17 Chief Financial Officer
FOLD Amicus Therapeutics Inc 2018-10-15 Chief Financial Officer
LIMIT LIMIT 2025-03-17 Chief Financial Officer

Baird William D Iii Latest Holdings Summary

Baird William D Iii currently owns a total of 3 stocks. Among these stocks, Baird William D Iii owns 1,121,034 shares of 2seventy bio Inc (TSVT) as of March 17, 2025, with a value of $6 Million and a weighting of 88.89%. Baird William D Iii owns 117,622 shares of Amicus Therapeutics Inc (FOLD) as of October 15, 2018, with a value of $691,617 and a weighting of 10.97%. Baird William D Iii also owns 1,776 shares of bluebird bio Inc (BLUE) as of February 17, 2021, with a value of $8,844 and a weighting of 0.14%.

Latest Holdings of Baird William D Iii

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSVT 2seventy bio Inc 2025-03-17 1,121,034 5.00 5,605,170
FOLD Amicus Therapeutics Inc 2018-10-15 117,622 5.88 691,617
BLUE bluebird bio Inc 2021-02-17 1,776 4.98 8,844

Holding Weightings of Baird William D Iii


Baird William D Iii Form 4 Trading Tracker

According to the SEC Form 4 filings, Baird William D Iii has made a total of 12 transactions in 2seventy bio Inc (TSVT) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in 2seventy bio Inc is the sale of 5,092 shares on March 17, 2025, which brought Baird William D Iii around $25,205.

According to the SEC Form 4 filings, Baird William D Iii has made a total of 0 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years. The most-recent trade in Amicus Therapeutics Inc is the sale of 10,000 shares on October 15, 2018, which brought Baird William D Iii around $122,300.

According to the SEC Form 4 filings, Baird William D Iii has made a total of 3 transactions in bluebird bio Inc (BLUE) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in bluebird bio Inc is the sale of 35 shares on February 17, 2021, which brought Baird William D Iii around $19,515.

Insider Trading History of Baird William D Iii

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Baird William D Iii Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Baird William D Iii Ownership Network

Ownership Network List of Baird William D Iii

No Data

Ownership Network Relation of Baird William D Iii

Insider Network Chart


Baird William D Iii Owned Company Details

What does Axcella Health Inc do?

Who are the key executives at Axcella Health Inc?

Baird William D Iii is the director of Axcella Health Inc. Other key executives at Axcella Health Inc include Senior Vice President & CIPO Paul Fehlner , director & President and CEO William Hinshaw , and 10 percent owner L.p. Fpa, .

Axcella Health Inc (AXLA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Axcella Health Inc (AXLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Axcella Health Inc (AXLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Axcella Health Inc (AXLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Axcella Health Inc Insider Transactions

No Available Data

Baird William D Iii Mailing Address

Above is the net worth, insider trading, and ownership report for Baird William D Iii. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Baird William D Iii's mailing address is: Cambridge Ma 02142.